MA35067B1 - Procédé pour éliminer une hémoglobine non modifiée de solutions d'hémoglobine réticulée contenant une hémoglobine polymère avec un appareil de traitement thermique de courte durée à haute tempé - Google Patents

Procédé pour éliminer une hémoglobine non modifiée de solutions d'hémoglobine réticulée contenant une hémoglobine polymère avec un appareil de traitement thermique de courte durée à haute tempé

Info

Publication number
MA35067B1
MA35067B1 MA36374A MA36374A MA35067B1 MA 35067 B1 MA35067 B1 MA 35067B1 MA 36374 A MA36374 A MA 36374A MA 36374 A MA36374 A MA 36374A MA 35067 B1 MA35067 B1 MA 35067B1
Authority
MA
Morocco
Prior art keywords
hemoglobin
short
high temperature
treatment apparatus
solutions containing
Prior art date
Application number
MA36374A
Other languages
English (en)
Inventor
Bing Lou Wong
Sui Yi Kwok
Original Assignee
Sui Yi Kwok
Billion King Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sui Yi Kwok, Billion King Int Ltd filed Critical Sui Yi Kwok
Publication of MA35067B1 publication Critical patent/MA35067B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne un procédé de traitement thermique de solutions d'hémoglobine réticulée contenant une hémoglobine polymère. Le procédé comprend le contact de la solution d'hémoglobine avec un appareil de traitement thermique de courte durée à haute température. Le procédé de traitement de courte durée à haute température permet de dénaturer par voie thermique l'hémoglobine tétramère non modifiée (hémoglobine sous forme de dimère), les impuretés protéiques (par exemple, l'immunoglobine G, la sérumalbumine), les bactéries et les virus, ce qui permet d'éviter les lésions rénales, les effets néfastes pour les vaisseaux et d'autres réactions de toxicité.
MA36374A 2011-04-29 2012-04-23 Procédé pour éliminer une hémoglobine non modifiée de solutions d'hémoglobine réticulée contenant une hémoglobine polymère avec un appareil de traitement thermique de courte durée à haute tempé MA35067B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201113097183A 2011-04-29 2011-04-29
US13/217,337 US8084581B1 (en) 2011-04-29 2011-08-25 Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
PCT/US2012/034608 WO2012148832A2 (fr) 2011-04-29 2012-04-23 Procédé pour éliminer une hémoglobine non modifiée de solutions d'hémoglobine réticulée contenant une hémoglobine polymère avec un appareil de traitement thermique de courte durée à haute température

Publications (1)

Publication Number Publication Date
MA35067B1 true MA35067B1 (fr) 2014-04-03

Family

ID=45349825

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36374A MA35067B1 (fr) 2011-04-29 2012-04-23 Procédé pour éliminer une hémoglobine non modifiée de solutions d'hémoglobine réticulée contenant une hémoglobine polymère avec un appareil de traitement thermique de courte durée à haute tempé

Country Status (18)

Country Link
US (1) US8084581B1 (fr)
EP (1) EP2702067B1 (fr)
KR (1) KR20140031915A (fr)
AP (1) AP2013007232A0 (fr)
AU (1) AU2012249996A1 (fr)
BR (1) BR112013027756A2 (fr)
CA (1) CA2834508A1 (fr)
CL (1) CL2013003111A1 (fr)
DK (1) DK2702067T3 (fr)
EA (1) EA020891B1 (fr)
ES (1) ES2668674T3 (fr)
IL (1) IL229107B (fr)
MA (1) MA35067B1 (fr)
MX (1) MX353814B (fr)
MY (1) MY162401A (fr)
SG (1) SG194677A1 (fr)
WO (1) WO2012148832A2 (fr)
ZA (1) ZA201308059B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2612752T3 (es) 2003-12-18 2017-05-18 Metronom Health, Inc. Biosensor implantable y métodos de uso del mismo
US8730976B2 (en) 2004-08-17 2014-05-20 Cisco Technology, Inc. System and method for preventing erroneous link aggregation due to component relocation
CN103781489B (zh) 2011-09-06 2017-03-29 黄炳镠 用于基于血红蛋白的氧载体的口服递送
US9636404B2 (en) * 2013-05-13 2017-05-02 Vision Global Holdings Ltd. Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
US9814759B2 (en) 2014-07-02 2017-11-14 Cheer Global Ltd. Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment
US9763889B2 (en) 2015-06-29 2017-09-19 Billion King International Ltd. Oral delivery system for hemoglobin based oxygen carriers
JP2018535189A (ja) 2015-09-02 2018-11-29 メトロノーム・ヘルス、インコーポレイテッド 光−酵素検体センサを使用する連続ヘルス・モニタリングのためのシステム及び方法
US10052290B2 (en) 2016-02-04 2018-08-21 Billion King International Ltd. Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
CA3070172A1 (fr) 2017-07-18 2019-01-24 VirTech Bio, Inc. Substituts sanguins comprenant de l'hemoglobine et procedes de fabrication

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925344A (en) * 1973-04-11 1975-12-09 Community Blood Council Plasma protein substitute
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4529719A (en) 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
FR2548671B1 (fr) 1983-07-07 1986-05-02 Merieux Inst Procede de preparation de globine a partir d'hemoglobine et globine obtenue par ce procede
US5281579A (en) * 1984-03-23 1994-01-25 Baxter International Inc. Purified virus-free hemoglobin solutions and method for making same
US4831012A (en) 1984-03-23 1989-05-16 Baxter International Inc. Purified hemoglobin solutions and method for making same
USRE34271E (en) 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4598064A (en) 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US4600531A (en) 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US5464814A (en) 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
JPH0750329B2 (ja) 1986-06-23 1995-05-31 富士写真フイルム株式会社 画像形成材料
US5084558A (en) 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
US5753616A (en) 1986-11-10 1998-05-19 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5955581A (en) 1986-11-10 1999-09-21 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
CA1312009C (fr) 1986-11-10 1992-12-29 Carl W. Rausch Substitut sanguin semi-synthetique extra pur
US5189146A (en) 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
WO1989012456A1 (fr) 1988-06-15 1989-12-28 Baxter International Inc. Procede de purification d'hemoglobine reticulee
US5439882A (en) 1989-12-29 1995-08-08 Texas Tech University Health Sciences Center Blood substitute
WO1992003153A1 (fr) * 1990-08-17 1992-03-05 Baxter International Inc. Composition a base d'hemoglobine-oligomere et procede de preparation
US5250665A (en) 1991-05-31 1993-10-05 The University Of Toronto Innovations Foundation Specifically β-β cross-linked hemoglobins and method of preparation
US5344393A (en) 1992-02-28 1994-09-06 Alliance Pharmaceutical Corp. Use of synthetic oxygen carriers to facilitate oxygen delivery
US6187744B1 (en) 1992-03-11 2001-02-13 Michael W. Rooney Methods and compositions for regulating the intravascular flow and oxygenating activity of hemoglobin in a human or animal subject
US5840851A (en) 1993-07-23 1998-11-24 Plomer; J. Jeffrey Purification of hemoglobin
US5725839A (en) 1993-08-16 1998-03-10 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
US5741893A (en) 1993-08-16 1998-04-21 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5807831A (en) 1993-08-16 1998-09-15 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5767089A (en) 1993-08-16 1998-06-16 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5804561A (en) 1993-08-16 1998-09-08 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5824781A (en) 1993-08-16 1998-10-20 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5840701A (en) 1993-08-16 1998-11-24 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
TW381022B (en) 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
US5817632A (en) 1993-08-16 1998-10-06 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5631219A (en) 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
WO1995031727A1 (fr) 1994-05-13 1995-11-23 Therasorb Medizinische Systeme Gmbh Colonne sterile et apyrogene couplee a une proteine en vue de la fixation et de l'extraction de substances donnees du sang
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
US6288027B1 (en) 1995-03-23 2001-09-11 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US6610832B1 (en) 1995-03-23 2003-08-26 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US5895810A (en) 1995-03-23 1999-04-20 Biopure Corporation Stable polymerized hemoglobin and use thereof
US5952470A (en) * 1995-06-07 1999-09-14 Biopure Corporation Method for separating unmodified hemoglobin from cross-linked hemoglobin
US5865784A (en) 1995-06-07 1999-02-02 Alliance Pharmaceutical Corp. Method of hemodilution facilitated by monitoring oxygenation status
US5691453A (en) 1995-06-07 1997-11-25 Biopure Corporation Separation of polymerized hemoglobin from unpolymerized hemoglobin on hydroxyapatite using HPLC
US5741894A (en) 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
JP2000502058A (ja) 1995-11-30 2000-02-22 ソマトジェン，インコーポレイテッド ヘモグロビン架橋の際の機能性制御のための方法
ES2205074T3 (es) 1996-03-21 2004-05-01 KOBUSCH-SENGEWALD GMBH & CO.KG Pelicula multicapa y procedimiento para su produccion, y su utilizacion.
DE69733664T3 (de) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
DE69831248T2 (de) 1997-02-28 2006-04-13 The Regents Of The University Of California, Oakland Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
US5814601A (en) 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
JP4643004B2 (ja) 1998-01-06 2011-03-02 シーラス コーポレイション 生体材料中の病原体不活性化剤をクエンチするための方法
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
US6747132B2 (en) 2000-11-29 2004-06-08 Apex Biosciences, Inc. Methods for the synthesis of a modified hemoglobin solution
US6518010B2 (en) 2001-02-28 2003-02-11 Biopure Corporation Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier
MXPA03009555A (es) 2001-04-18 2004-12-06 Northfield Lab Sistema de recipiente flexible para almacenamiento de soluciones de hemoglobina estabilizadas.
JP4260417B2 (ja) 2001-05-23 2009-04-30 ノバルティス アクチエンゲゼルシャフト 溶液を輸送し脱酸素するためのシステム及び方法
US7038016B2 (en) 2001-08-21 2006-05-02 Apex Bioscience, Inc. Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution
US20030153491A1 (en) 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20050164915A1 (en) 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
CN1741812B (zh) 2002-12-23 2013-04-24 犹太大学阿尔伯特爱因斯坦医学院 修饰的血红蛋白及其制备方法
CN100431602C (zh) 2003-01-29 2008-11-12 北原实验室有限公司 具有低量四聚体的聚合血红蛋白溶液及制备方法
US7135554B1 (en) * 2004-01-27 2006-11-14 Biopure Corporation Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
BRPI0518198B8 (pt) 2004-10-29 2021-06-22 Cerus Corp método ex vivo para tratar uma composição de células hemácias para inativar um patógeno, se presente, bem como composição e kit
WO2007065265A1 (fr) 2005-12-08 2007-06-14 Ronald Kluger Réactifs de réticulation pour hémoglobine et produits à base d'hémoglobine réticulés à l'aide desdits réactifs
US7759306B2 (en) 2006-05-16 2010-07-20 Simoni Jan S Methods of treating acute blood loss
US7795401B2 (en) 2006-09-06 2010-09-14 National Chung Cheng University Modified hemoglobin with allosteric effector conjugated
US7494974B2 (en) 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
US7504377B2 (en) 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition

Also Published As

Publication number Publication date
AP2013007232A0 (en) 2013-11-30
EP2702067B1 (fr) 2018-02-21
CL2013003111A1 (es) 2014-08-29
SG194677A1 (en) 2013-12-30
CA2834508A1 (fr) 2012-11-01
WO2012148832A2 (fr) 2012-11-01
AU2012249996A1 (en) 2013-11-21
EP2702067A4 (fr) 2015-12-30
EA020891B1 (ru) 2015-02-27
WO2012148832A8 (fr) 2013-04-25
MX2013012614A (es) 2014-08-22
MX353814B (es) 2018-01-31
MY162401A (en) 2017-06-15
IL229107B (en) 2018-06-28
EA201101154A1 (ru) 2012-10-30
IL229107A0 (en) 2013-12-31
KR20140031915A (ko) 2014-03-13
ES2668674T3 (es) 2018-05-21
EP2702067A2 (fr) 2014-03-05
NZ617344A (en) 2015-12-24
US8084581B1 (en) 2011-12-27
BR112013027756A2 (pt) 2017-01-03
ZA201308059B (en) 2020-02-26
DK2702067T3 (en) 2018-05-22

Similar Documents

Publication Publication Date Title
MA35067B1 (fr) Procédé pour éliminer une hémoglobine non modifiée de solutions d'hémoglobine réticulée contenant une hémoglobine polymère avec un appareil de traitement thermique de courte durée à haute tempé
Lazarou Keeping the immune system in check: a role for mitophagy
Knight et al. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis
Seelen et al. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus
JP2016511238A5 (fr)
JP2018516944A5 (fr)
EP4234569A3 (fr) Procédé et utilisation d'inactivation continue de virus pendant la fabrication de produit biologique
RU2015125059A (ru) Обработка табачного материала
MX2016016907A (es) Metodo para eliminar contaminantes virales de extractos pancreaticos.
JP2012233753A5 (fr)
Valdes et al. Segmental heterogeneity in Bcl‐2, Bcl‐xL and Bax expression in rat tubular epithelium after ischemia‐reperfusion
Mocchegiani et al. Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis.
Hepburn et al. Complement, roles in renal disease and modulation for therapy.
Bots et al. Herpesvirus microRNAs for use in gene therapy immune-evasion strategies
RU2007125042A (ru) Способ уплотнения отливок из никелевого сплава
Lv et al. Entecavir promotes CD34+ stem cell proliferation in the peripheral blood and liver of chronic hepatitis B and liver cirrhosis patients
Genre et al. HLA‐G 14‐bp Ins/Ins Genotype in Patients Harbouring Helicobacter pylori Infection: A Potential Risk Factor?
Li et al. Functional expression and characterization of a cytosolic copper/zinc-superoxide dismutase of Spirometra erinacei
Fonseca et al. Autoimmunity and hypertension
Vyshnavi et al. Invitro removal of nickel (II) by Allium cepa skin as an absorbent
MA44836A (fr) Procédés de traitement du syndrome polykystique des reins
JP2022174674A (ja) ウイルス検出方法及びウイルス検出装置
Szymczak et al. The use of different dialysis membranes in therapy of patients with multiple myeloma.
Sanna et al. Evaluation of EZH2 expression in hepatitis B patients
van der Schoot et al. Obstructive azoospermia in men who wish to father children; diagnosis and surgical sperm retrieval